Retina — Macular disease
Epiretinal membrane: diagnosis and treatment
An epiretinal membrane is a thin fibrous layer that develops on the surface of the macula, causing progressive visual distortion. Treatment is surgical when it affects vision.
What is an epiretinal membrane?
The epiretinal membrane (ERM), also called macular pucker or epimacular membrane, is a thin layer of fibrocellular tissue that forms on the surface of the retina at the level of the macula — the central zone of precise vision. As it gradually contracts, it distorts the retinal layers and impairs central vision.
It is described as idiopathic when it occurs in the context of an age-related posterior vitreous detachment, most often after age 50. It can also be secondary to a retinal condition : a tear, a detachment, diabetic retinopathy, uveitis or venous occlusion.
Its prevalence increases with age : around 7 % after age 60 and 12 % after age 70 in epidemiological studies.
Symptoms
The main symptom is metamorphopsia : straight lines appear distorted, wavy or curved. Patients describe doors or windows that seem to « lean », or a line of writing that is not straight.
- Metamorphopsia — distortion of straight lines, assessed with the Amsler grid
- Progressive decline in central visual acuity — especially for reading
- Blurred or veiled vision in the centre of the visual field
- Monocular diplopia in some advanced cases
The Amsler grid allows for self-monitoring at home : stare at the central dot of the grid with one eye closed. If any lines appear curved or missing, consult an ophthalmologist. This test does not replace macular OCT but indicates the need for an examination.
Diagnosis by macular OCT
The diagnosis is confirmed by macular OCT, which directly visualises the membrane on the surface of the retina, quantifies macular thickness and assesses the integrity of the underlying photoreceptor layers — a determining factor in estimating the potential for visual recovery after surgery.
Cachan
OCT Zeiss Cirrus 6000 — macular mapping, analysis of the retinal layers, central thickness.
Paris 13
OCT Toward Pi YAlkai — macular follow-up of patients with a membrane secondary to diabetic retinopathy or venous occlusion.
Surgical indication
Bothersome metamorphopsia + progressive decline in acuity + intact retinal layers on OCT. A slowly progressing membrane may simply be monitored.
Vitrectomy with macular peeling
The only effective treatment is surgical. It relies on pars plana vitrectomy (three microincisions of less than one millimetre) with peeling of the membrane using a micro-forceps, performed under vital staining. An associated peeling of the internal limiting membrane (ILM) is commonly performed to reduce the risk of recurrence, estimated at less than 5 % of cases.
Location & anaesthesia
Clinique Sainte-Geneviève — Paris 14 (29 rue Sarrette)
Outpatient surgery — home the same day
Loco-regional anaesthesia (peribulbar)
3D visualisation
Zeiss Artevo 800 microscope — digital 3D heads-up visualisation on a 55″ 4K screen. It includes an intraoperative OCT allowing the membrane peeling to be monitored in real time during the procedure.
Results and visual recovery
Visual recovery is progressive over 3 to 12 months. In a large series of 504 eyes, a gain of at least two lines of acuity was observed in 48 % of cases at 12 months (PMID 25574782). The improvement is maintained over the long term : a prospective study confirmed a lasting positive effect on visual quality of life at 2 years (PMID 35169203).
The outcome depends mainly on the state of the photoreceptor layers before surgery : a membrane diagnosed early with intact layers gives better results. The preoperative OCT analysis makes it possible to assess this potential during the consultation.
Postoperative course
- Home the same day
- No particular positioning required after the operation (unlike with a macular hole)
- Antibiotic and anti-inflammatory eye drops for 4 to 6 weeks
- Time off work of 1 to 2 weeks depending on the activity
- Postoperative follow-up : D1, D7, D30, D90 with control macular OCT
References
1. Schechet SA et al. Results and prognostic factors for visual improvement after pars plana vitrectomy for idiopathic epiretinal membrane. Retina. 2015;35(5):880–886. PMID 25574782
2. Khanna RK et al. Long-term functional outcomes and vision-related quality of life after vitrectomy for epiretinal membrane: a prospective cohort study. Sci Rep. 2022;12:2470. PMID 35169203
3. Mahmoudzadeh R, Khan MA. Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane: OCT Biomarkers of Visual Outcomes in 322 Eyes. Ophthalmol Retina. 2022. PMID 34718218
Frequently asked questions
Diagnosis & Surgery
Consult for an epiretinal membrane
Macular OCT and surgical decision in Cachan or Paris 13. Vitrectomy with peeling under the Artevo 800 3D microscope at the Clinique Sainte-Geneviève (Paris 14).